Walvax沃森生物

CN
EN

00

-0.22 (-0.6%)

Stock Code: 300142

Key Facts

5.3 billion

USD 5.3 billion market capitalization

706.4 million

USD 706.4 million revenue in 2022

152.7 million

USD 152.7 million operating profit in 2022

70.4%

70.4% increase in net profit attributable to Company owners in 2022

480.9 million

USD 480.9 million revenue in 2021

98.7 million

USD 98.7 million operating profit in 2021
2023.10.31
2023 Third-Quarter Report
2023.08.28
2023 Interim Report
2023.04.24
2023 First-Quarter Report
2023.04.03
2022 Annual Report
2022.08.11
2022 Interim Report
2022.03.21
2021 Annual Report
2021.03.21
2020 Annual Report
2020.03.21
2019 Annual Report